PerspectiveCANCER

Quo Vadis, Specificity?

See allHide authors and affiliations

Science  11 Jan 2008:
Vol. 319, Issue 5860, pp. 164-165
DOI: 10.1126/science.1153713

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Mutations in cancer cells can give rise to tumor-specific antigens, but abnormal processing of normal molecules in these cells can also elicit an immune response.